Program subject to change
By Invitation Only
By Invitation Only
The session will introduce you to health economics as a sub-discipline of economics and its relevance to decision making in the healthcare sector.
The first part of the session will provide an overview of the principal concepts and theoretical foundations of health economics and how these help us to understand how healthcare markets work; the various market failures that can arise in healthcare; and the role of governments in regulating, funding and providing healthcare.
The second part of the session will introduce the methods and use of economic evaluation of healthcare, and how these can be used to assess value for money in decisions affecting the allocation of health care budgets.
This session will introduce health technology assessment (HTA), the context of how it fits into healthcare decision-making and its relevance to evidence based health policy and the implementation of efficient healthcare.
After providing an overview of the HTA journey (including horizon scanning), the key models and components of HTA, including health economics, different approaches of HTA implementation will be presented, including the initiative of the European Union for HTA collaboration.
The session will explore which HTA deliverables are more transferable across countries to reduce duplication of efforts.
Finally the session will introduce the concept of extended value framework for health technologies, and how the transparency and consistency of decisions may be improved by applying multi-criteria decision analysis (MCDA) based on different domains of HTA and the value framework.
In cooperation with The Department of Tourism and Commerce Marketing (DTCM) – Dubai Business Events
This session will discuss the role which health economics and outcomes research plays in healthcare decisions, drawing on the experience of the United Kingdom, USA, United Arab Emirates and Egypt.
Role of HEOR in Decisions – a UK Perspective
US Value Frameworks and Implications for Health Outcomes Research
Presentations from a MENA Region Perspective
Healthcare policy makers across the region are currently exploring options to establish HTA in their country. Frequently, opportunities and limitations of HTA to effectively address decision-making objectives and constraints are not well characterized or understood.
Process of improving patient access to innovative health technologies can benefit from alignment of realistic expectations towards HTA and evidence-informed decision- making.
During this session the following aspects, among others, will be addressed form the multi-stakeholder perspective:
MENA Region panelists:
The objective of the session will be to highlight and discuss a number of significant challenges in pricing and reimbursement facing the countries in the region, in their pursuit to contain costs, improve efficient allocation of resources and enable faster access to new therapies. Specifically, the panel will discuss the following themes:
Associate Professor in International Health Policy in the Department of Health Policy at London School of Economics and Political Science
Deputy Director at LSE Health and Program Director of the Medical Technology Research Group (MTRG)
London, United Kingdom
MENA Region panelists:
Senior Director – Public Affairs
Middle East & North Africa Region, Novartis
United Arab Emirates
Gihan Hamdy Elsisi Msc, PhD
Head of Pharmacoeconomic Unit, Central Administration for Pharmaceutical Affairs
Ministry Of Health
Abdulaziz H. Al-Saggabi, BSc, MSc, PharmD
Director, Drug Policy & Economics Center
Ministry of National Guard Health Affairs
Shadi Saleh, PhD
Associate Vice President for Health Affairs and Professor of Health Systems and Financing,
American University of Beirut
The costs associated with opportunities forgone in inappropriate health policy decisions is especially high in countries with economic recession. Application of health technology assessment (HTA) informing policy decisions (eg, pricing, reimbursement) can improve the allocative efficiency of scarce resources contributing to optimal distribution of goods and services while taking into account patients’ and consumers’ preferences. Development and implementation of an HTA system could benefit from the knowledge transfer from other countries where such a system has been established thus, eg, avoiding the mistakes the others made. At the same time, realistic assessment of the specific economic and governance situations in the countries of the MENA region must be considered when developing an appropriate roadmap for HTA implementation responsive to the local needs.
This session aims to describe the main HTA implementation scenarios in the MENA countries and summarize the most important questions related to capacity building, financing HTA, process and organizational structure for HTA, standardization of HTA methodology, use of local data, scope of mandatory HTA, and decision criteria. The panel session – including introductory presentation and roundtable discussion – will help clarifying (1) long-term objectives and (2) immediate possible steps of HTA implementation in the MENA region.
Zoltán Kaló, PhD
Professor of Health Economics, Department of Health Policy and Economics
Institute of Economics, Faculty of Social Sciences, Eötvös Loránd University (ELTE)
Finn Børlum Kristensen, MD, PhD
Professor in Health Services Research and HTA at Department of Public Health
Research Unit of User Perspectives, University of Southern Denmark
MENA Region speakers:
Maryam Alowayesh, MSc, PhD
School of Pharmacy, Kuwait University
Mohsen George, MD
Vice President, Health Insurance Organization
First Undersecretary, Ministry of Health
Abeer A. Al-Rabayah, BSc, MBA, MSc
Head, Center for Drug Policy & Technology Assessment (CDPTA)
King Hussein Cancer Center
Rita Karam, PharmD, PhD
Director, Quality Assurance of Pharmaceutical Products
Ministry of Health
Mouna Jameleddine, PharmD, MSc
Head, Health Technology Assessment Department
National Instance for Assessment & Accreditation in Healthcare – INASanté
Ahmad Nadeer Fasseeh, BPharm, MBA
Doctoral School of Sociology at Eötvös Loránd University (ELTE)